These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 18514935

  • 1. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M, Aspromonte N, Milani L, Bobbio M, Bardellotto S, Barro S, Giovinazzo P, Noventa F, Valle R.
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [Abstract] [Full Text] [Related]

  • 2. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G, Barro S, Giovinazzo P, Milani L, Lorusso R, Dei Cas L.
    Int J Cardiol; 2010 Apr 01; 140(1):88-94. PubMed ID: 19321212
    [Abstract] [Full Text] [Related]

  • 3. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.
    Am Heart J; 2003 Oct 01; 146(4):729-35. PubMed ID: 14564330
    [Abstract] [Full Text] [Related]

  • 4. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL, Robert A, Ahn S, van Linden F, Ketelslegers JM, Pouleur H, Rousseau MF.
    J Card Fail; 2000 Sep 01; 6(3):201-7. PubMed ID: 10997745
    [Abstract] [Full Text] [Related]

  • 5. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.
    Int J Cardiol; 2005 Sep 15; 104(1):39-45. PubMed ID: 16137508
    [Abstract] [Full Text] [Related]

  • 6. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S, Gorini M, Salio M, Lucci D, Latini R, Maggioni AP.
    Ital Heart J; 2000 Apr 15; 1(4):282-8. PubMed ID: 10824729
    [Abstract] [Full Text] [Related]

  • 7. Multiparametric risk stratification in patients with mild to moderate chronic heart failure.
    Scardovi AB, De Maria R, Coletta C, Aspromonte N, Perna S, Cacciatore G, Parolini M, Ricci R, Ceci V.
    J Card Fail; 2007 Aug 15; 13(6):445-51. PubMed ID: 17675058
    [Abstract] [Full Text] [Related]

  • 8. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R, Aspromonte N, Feola M, Milli M, Canali C, Giovinazzo P, Carbonieri E, Ceci V, Cerisano S, Barro S, Milani L.
    J Card Fail; 2005 Sep 15; 11(7):498-503. PubMed ID: 16198244
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N, Nakatani S, Umemura S, Kimura K, Kitakaze M.
    J Am Soc Echocardiogr; 2011 Sep 15; 24(9):984-91. PubMed ID: 21570253
    [Abstract] [Full Text] [Related]

  • 10. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981
    [Abstract] [Full Text] [Related]

  • 11. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U, Albåge A, Larsson PT, Insulander P, Lindblom D.
    Eur J Cardiothorac Surg; 2007 May 22; 31(5):922-8. PubMed ID: 17321144
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R.
    Am J Cardiol; 2008 Aug 15; 102(4):469-74. PubMed ID: 18678308
    [Abstract] [Full Text] [Related]

  • 13. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure.
    Feola M, Menardi E, Ribichini F, Vado A, Deorsola A, Ferrero V, Visconti G, Milanese U, Uslenghi E.
    Med Sci Monit; 2003 Aug 15; 9(8):CR341-5. PubMed ID: 12942029
    [Abstract] [Full Text] [Related]

  • 14. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
    Zhao XY, Yang YJ, Zhang J, Dang AM, Ni XH, Huang J, Kang S, Ma WH, Zhao DY.
    Zhonghua Yi Xue Za Zhi; 2006 May 09; 86(17):1165-9. PubMed ID: 16796855
    [Abstract] [Full Text] [Related]

  • 15. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R, Rapid Emergency Department Heart Failure Outpatient Trial investigators.
    J Am Coll Cardiol; 2004 Sep 15; 44(6):1328-33. PubMed ID: 15364340
    [Abstract] [Full Text] [Related]

  • 16. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM, Zaninotto M, Bacchiega E, Nalli C, Forni M, Tiso E, Cacciavillani L, Razzolini R, Plebani M.
    Ital Heart J; 2005 Feb 15; 6(2):125-32. PubMed ID: 15819505
    [Abstract] [Full Text] [Related]

  • 17. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP, Lowes BD, Grayburn PA, White M, Krause-Steinrauf H, Krishnan V, Uyeda L, Burnett JC, BEST Neurohumoral Substudy Investigators.
    J Card Fail; 2007 Aug 15; 13(6):437-44. PubMed ID: 17675057
    [Abstract] [Full Text] [Related]

  • 18. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
    Hogenhuis J, Jaarsma T, Voors AA, Hillege HL, Lesman I, van Veldhuisen DJ.
    Int J Cardiol; 2006 Mar 22; 108(1):63-7. PubMed ID: 16516699
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 20. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T, Kato M, Ogino K, Osaki S, Igawa O, Hisatome I, Shigemasa C.
    J Card Fail; 2003 Aug 15; 9(4):318-24. PubMed ID: 13680553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.